{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:05:44Z","timestamp":1792638344982,"version":"4.5.0"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117204","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:05:39Z","timestamp":1786025139000},"page":"117204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["HMGB1 signalling in Alzheimer\u2019s disease: pathogenic roles and therapeutic prospects"],"prefix":"10.1016","volume":"187","author":[{"given":"Prashant","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajjwal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishika","family":"Dhapola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Paidlewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibbanti","family":"HariKrishnaReddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117204_bb0005","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10495-023-01848-y","article-title":"Apoptosis in alzheimer\u2019s disease: insight into the signaling pathways and therapeutic avenues","volume":"28","author":"Kumari","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2026.117204_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112940","article-title":"Unveiling the role of astrogliosis in alzheimer\u2019s disease pathology: insights into mechanisms and therapeutic approaches","volume":"141","author":"Paidlewar","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.117204_bb0015","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0197-4580(98)00033-5","article-title":"Alzheimer\u2019s disease as proteolytic disorders: anabolism and catabolism of \u03b2-amyloid","volume":"19","author":"Saido","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.intimp.2026.117204_bb0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of alzheimer disease: back to the future","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.117204_bb0025","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1007\/s12035-024-04545-2","article-title":"Association between the gut microbiota and alzheimer\u2019s disease: an update on signaling pathways and translational therapeutics","volume":"62","author":"Kulkarni","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0030","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer\u2019s disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2026.117204_bb0035","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2174\/1567205014666170317113606","article-title":"Impact of cytokines and chemokines on Alzheimer\u2019s disease neuropathological hallmarks","volume":"14","author":"Domingues","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0040","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease","volume":"29","author":"Dhapola","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2026.117204_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020383","article-title":"Impact of HMGB1, RAGE, and TLR4 in alzheimer\u2019s disease (AD): from risk factors to therapeutic targeting","volume":"9","author":"Paudel","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.117204_bb0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117204_bb0055","article-title":"Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes., Swiss Med","volume":"141","author":"Pisetsky","year":"2011","journal-title":"Wkly"},{"key":"10.1016\/j.intimp.2026.117204_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s10020-021-00307-1","article-title":"Redox modifications of cysteine residues regulate the cytokine activity of HMGB1","volume":"27","author":"Yang","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14728222.2018.1439924","article-title":"Extracellular HMGB1 as a therapeutic target in inflammatory diseases","volume":"22","author":"Andersson","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2026.117204_bb0070","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.13799","article-title":"HMGB1-activatied NLRP3 inflammasome induces thrombocytopenia in heatstroke rat","volume":"10","author":"Yin","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.intimp.2026.117204_bb0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","article-title":"Toll-like receptors and innate immunity","volume":"388","author":"Kumar","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2026.117204_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.expneurol.2011.08.012","article-title":"High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products","author":"Mazarati","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2026.117204_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1134\/S0006350921030039","article-title":"The Structural Organization of the HMGB1 Nuclear Protein and Its Effect on the Formation of Ordered Supramolecular Complexes","volume":"66","author":"Chikhirzhina","year":"2021","journal-title":"Biophysics (Oxf)."},{"key":"10.1016\/j.intimp.2026.117204_bb0095","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1021\/bi049364k","article-title":"The Long Acidic Tail of High Mobility Group Box 1 (HMGB1) Protein Forms an Extended and Flexible Structure That Interacts with Specific Residues within and between the HMG Boxes","volume":"43","author":"Knapp","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.intimp.2026.117204_bb0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2796.2003.01296.x","article-title":"In macrophages, intracellular HMGB1 has been found to mediate autophagy and prevent macrophage cell death from bacterial infection and endotoxemia","volume":"255","author":"M\u00fcller","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0105","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/eji.201141391","article-title":"Identification of lipopolysaccharide-binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse model","volume":"41","author":"Youn","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2026.117204_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/JLB.3MIR1218-497R","article-title":"Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation","volume":"106","author":"Deng","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2026.117204_bb0115","first-page":"163","article-title":"HMGB1 and its physiological and pathological roles","volume":"113","author":"Naglova","year":"2012","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.intimp.2026.117204_bb0120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.emboj.7601552","article-title":"A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin","volume":"26","author":"Orlova","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2026.117204_bb0125","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.bcp.2004.03.048","article-title":"High mobility group box 1 protein, a cue for stem cell recruitment","volume":"68","author":"Palumbo","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117204_bb0130","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/ATVBAHA.107.153429","article-title":"Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration","volume":"27","author":"De Mori","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2026.117204_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2119\/2008-00034.Klune","article-title":"HMGB1: endogenous danger signaling","volume":"14","author":"Klune","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0140","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/sj.jid.5701212","article-title":"High-mobility group box 1 protein in human and murine skin: involvement in wound healing","volume":"128","author":"Straino","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2026.117204_bb0145","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0150","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","author":"Venereau","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0155","article-title":"HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target","volume":"13-2022","author":"Mao","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2026.117204_bb0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12974-016-0670-z","article-title":"HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease","volume":"13","author":"Festoff","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117204_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/08916930903384591","article-title":"RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1\/DNA immune complexes","volume":"43","author":"Avalos","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2026.117204_bb0170","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.2337\/db15-0575","article-title":"RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes","volume":"64","author":"Daffu","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2026.117204_bb0175","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/eji.200526066","article-title":"Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells","volume":"35","author":"Dumitriu","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2026.117204_bb0180","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","article-title":"The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin: Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system (\u2217)","volume":"270","author":"Hori","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117204_bb0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10571-015-0233-3","article-title":"Role of RAGE in Alzheimer\u2019s disease","volume":"36","author":"Cai","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0190","series-title":"Advanced glycation end products: A risk factor for human health, in: Ann. Pharm. Fr","first-page":"400","author":"Wautier","year":"2014"},{"key":"10.1016\/j.intimp.2026.117204_bb0195","series-title":"The Immune Tolerance Role of the HMGB1-RAGE Axis","volume":"5","author":"Watanabe","year":"2021"},{"key":"10.1016\/j.intimp.2026.117204_bb0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuropharm.2014.09.019","article-title":"Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model","volume":"89","author":"Lv","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2026.117204_bb0205","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/754069","article-title":"Overexpression of receptor for advanced glycation end products and high-mobility group box 1 in human dental pulp inflammation","volume":"2014","author":"Tancharoen","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2026.117204_bb0210","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3892\/mmr.2014.3113","article-title":"Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells","volume":"11","author":"Di","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2026.117204_bb0215","first-page":"720","article-title":"AGEs and RAGE-advanced glycation end-products and their receptor in questions and answers","volume":"60","author":"Kalousov\u00e1","year":"2014","journal-title":"Vnitr. Lek."},{"key":"10.1016\/j.intimp.2026.117204_bb0220","article-title":"Amphoterin as an extracellular regulator of cell motility: from discovery to disease","volume":"255","author":"Huttunen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","article-title":"Blockade of RAGE\u2013amphoterin signalling suppresses tumour growth and metastases","volume":"405","author":"Taguchi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117204_bb0230","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbadis.2005.03.014","article-title":"RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling","volume":"1741","author":"Chaney","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA)-Molecular Basis Dis."},{"key":"10.1016\/j.intimp.2026.117204_bb0240","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/hmg\/ddy017","article-title":"RAGE mediates A\u03b2 accumulation in a mouse model of Alzheimer\u2019s disease via modulation of \u03b2-and \u03b3-secretase activity","volume":"27","author":"Fang","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.intimp.2026.117204_bb0245","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10571-015-0233-3","article-title":"Role of RAGE in Alzheimer\u2019s Disease","volume":"36","author":"Cai","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0250","series-title":"CaMKK\u03b2 is Involved in AMP-Activated Protein Kinase Activation by Baicalin in LKB1 Deficient Cell Lines","author":"Ma","year":"2012"},{"key":"10.1016\/j.intimp.2026.117204_bb0255","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1089\/ars.2013.5587","article-title":"CaMKK\u03b2-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation","volume":"21","author":"Zhou","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2026.117204_bb0260","first-page":"2652","article-title":"Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells, Blood","volume":"101","author":"Fiuza","year":"2003","journal-title":"J. Am. Soc. Hematol."},{"key":"10.1016\/j.intimp.2026.117204_bb0265","series-title":"Activation of Gene Expression in Human Neutrophils by High Mobility Group Box 1 Protein","first-page":"870","volume":"80262","author":"Park","year":"2026"},{"key":"10.1016\/j.intimp.2026.117204_bb0270","series-title":"Convergence and Amplification of Toll-Like Receptor (TLR) and Receptor for Advanced Glycation end Products (RAGE) Signaling Pathways Via High Mobility Group B1 (HMGB1)","first-page":"91","author":"Griffioen","year":"2008"},{"key":"10.1016\/j.intimp.2026.117204_bb0275","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.1900860","article-title":"Interplay between RAGE and TLR4 regulates HMGB1-induced inflammation by promoting cell surface expression of RAGE and TLR4","volume":"205","author":"Zhong","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.117204_bb0280","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fphar.2016.00369","article-title":"Curcumin represses NLRP3 inflammasome activation via TLR4\/MyD88\/NF-\u03baB and P2X7R signaling in PMA-induced macrophages","volume":"7","author":"Kong","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117204_bb0285","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.intimp.2018.12.027","article-title":"HMGB1 gene silencing inhibits neuroinflammation via down-regulation of NF-\u03baB signaling in primary hippocampal neurons induced by A\u03b225\u201335","volume":"67","author":"Nan","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.117204_bb0290","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/nu11040762","article-title":"Lycopene inhibits reactive oxygen species-mediated NF-\u03baB signaling and induces apoptosis in pancreatic cancer cells","volume":"11","author":"Jeong","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2026.117204_bb0295","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1523\/JNEUROSCI.3158-09.2009","article-title":"CD14 and toll-like receptors 2 and 4 are required for fibrillar A\u03b2-stimulated microglial activation","volume":"29","author":"Reed-Geaghan","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0300","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1159\/000110455","article-title":"Role of the toll-like receptor 4 in neuroinflammation in Alzheimer\u2019s disease","volume":"20","author":"Walter","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2026.117204_bb0305","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-4159.2007.05001.x","article-title":"Toll-like receptors 2 and 4 mediate A\u03b2 (1\u201342) activation of the innate immune response in a human monocytic cell line","volume":"104","author":"Udan","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.117204_bb0310","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2119\/molmed.2012.00314","article-title":"A Janus tale of two active high mobility group box 1 (HMGB1) redox states","volume":"18","author":"Tang","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0315","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.278.5343.1612","article-title":"IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling","volume":"278","author":"Muzio","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117204_bb0320","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s11064-019-02748-x","article-title":"Imbalance of microglial TLR4\/TREM2 in LPS-treated APP\/PS1 transgenic mice: a potential link between Alzheimer\u2019s disease and systemic inflammation","volume":"44","author":"Zhou","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0325","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","article-title":"TREM2 and the neuroimmunology of Alzheimer\u2019s disease","volume":"88","author":"Hickman","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117204_bb0330","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/brain\/awl249","article-title":"Role of toll-like receptor signalling in A\u03b2 uptake and clearance","volume":"129","author":"Tahara","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2026.117204_bb0335","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/cr.2008.78","article-title":"With a little help from my friends: modulation of phagocytosis through TLR activation","volume":"18","author":"Tricker","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0340","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0197-4580(95)00092-S","article-title":"Role of microglia in senile plaque formation","volume":"16","author":"Mackenzie","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.intimp.2026.117204_bb0345","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tips.2022.05.004","article-title":"Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions","volume":"43","author":"Squillace","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2026.117204_bb0350","article-title":"Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential, Immunity","volume":"11","author":"Dabi","year":"2023","journal-title":"Inflamm. Dis."},{"key":"10.1016\/j.intimp.2026.117204_bb0355","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2119\/molmed.2011.00327","article-title":"High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor","volume":"18","author":"Hreggvidsd\u00f3ttir","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0360","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-021-00409-z","article-title":"HMGB1 orchestrates STING-mediated senescence via TRIM30\u03b1 modulation in cancer cells","volume":"7","author":"Lee","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.117204_bb0365","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3390\/cells9122650","article-title":"High mobility group box-1 and blood\u2013brain barrier disruption","volume":"9","author":"Nishibori","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.117204_bb0370","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00401-016-1644-z","article-title":"Widespread tau seeding activity at early Braak stages","volume":"133","author":"Furman","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2026.117204_bb0375","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12974-019-1471-y","article-title":"A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury","volume":"16","author":"Kuwar","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117204_bb0380","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/ijms22094781","article-title":"Meta-analysis of methamphetamine modulation on amyloid precursor protein through HMGB1 in alzheimer\u2019s disease","volume":"22","author":"Alabed","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117204_bb0385","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/cells9020383","article-title":"Impact of HMGB1, RAGE, and TLR4 in alzheimer\u2019s disease (AD): from risk factors to therapeutic targeting","volume":"9","author":"Paudel","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.117204_bb0390","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0006-291X(03)00024-X","article-title":"Role of high mobility group protein-1 (HMG1) in amyloid-\u03b2 homeostasis","volume":"301","author":"Takata","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2026.117204_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2021.721474","article-title":"NLRP3 inflammasome-dependent increases in high mobility group box 1 involved in the cognitive dysfunction caused by tau-overexpression","volume":"13","author":"Zhao","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090426","article-title":"Microglia activated by excess cortisol induce HMGB1 acetylation and neuroinflammation in the hippocampal DG region of mice following cold exposure","volume":"9","author":"Xu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.117204_bb0405","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.117204_bb0410","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JAD-210268","article-title":"NLRP3 inflammasome: A starring role in amyloid-\u03b2- And tau-driven pathological events in alzheimer\u2019s disease","volume":"83","author":"Van Zeller","year":"2021","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.intimp.2026.117204_bb0415","doi-asserted-by":"crossref","first-page":"14885","DOI":"10.1021\/bi026469j","article-title":"Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments","volume":"41","author":"Barghorn","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.intimp.2026.117204_bb0420","first-page":"2006","article-title":"A\u03b2-HMGB1 complex is a pathogenic molecule at the advanced stage of Alzheimer\u2019s disease","author":"Tanaka","year":"2025","journal-title":"BioRxiv"},{"key":"10.1016\/j.intimp.2026.117204_bb0425","doi-asserted-by":"crossref","first-page":"31895","DOI":"10.1038\/srep31895","article-title":"HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer\u2019s disease","volume":"6","author":"Fujita","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117204_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102098","article-title":"Implicative role of cytokines in neuroinflammation mediated AD and associated signaling pathways: Current progress in molecular signaling and therapeutics","volume":"92","author":"Kumari","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.intimp.2026.117204_bb0440","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s12975-024-01258-5","article-title":"HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation","volume":"16","author":"Li","year":"2025","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0445","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1523\/JNEUROSCI.3732-10.2011","article-title":"HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration","volume":"31","author":"Gao","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2019.00380","article-title":"Detrimental Effects of HMGB-1 Require Microglial-Astroglial Interaction: Implications for the Status Epilepticus -Induced Neuroinflammation","volume":"13","author":"Rosciszewski","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109419","article-title":"Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer\u2019s disease and frontotemporal dementia","volume":"36","author":"Gaikwad","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.117204_bb0460","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117204_bb0465","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12035-011-8163-7","article-title":"Signaling pathways in reactive astrocytes, a genetic perspective","volume":"43","author":"Kang","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0470","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cytogfr.2024.06.002","article-title":"The impact of cytokines in neuroinflammation-mediated stroke","volume":"78","author":"Kumari","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2026.117204_bb0475","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1369-5274(99)80033-2","article-title":"Oxidative stress","volume":"2","author":"Storz","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0480","first-page":"1105","article-title":"Oxidative Stress","volume":"57","author":"Eric","year":"2017","journal-title":"Synaptic Dysfunction, and Alzheimer\u2019 s Disease"},{"key":"10.1016\/j.intimp.2026.117204_bb0485","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2026.117204_bb0490","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.neuron.2023.02.019","article-title":"Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration","volume":"111","author":"Neel","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.117204_bb0495","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1091\/mbc.E16-05-0313","article-title":"Amyloid \u03b2-peptides interfere with mitochondrial preprotein import competence by a coaggregation process","volume":"27","author":"Cenini","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.intimp.2026.117204_bb0500","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.nbd.2014.12.025","article-title":"According to a research, complex I within the mitochondrial ETC may be impaired as a result of mitochondrial ROS (mtROS). Consequently, the effectiveness of mitochondrial OXPHOS is decreased","volume":"75","author":"Rowley","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.117204_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111615","article-title":"HMGB1 promotes LPS-induced M1 polarization and apoptosis in microglia by mediating the expression of immune and inflammation-related genes","volume":"233","author":"Zhao","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2026.117204_bb0510","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1523\/JNEUROSCI.3732-10.2011","article-title":"HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration","volume":"31","author":"Gao","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0515","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","article-title":"The PI3K\/Akt signaling axis in Alzheimer\u2019s disease: a valuable target to stimulate or suppress?","volume":"26","author":"Razani","year":"2021","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.intimp.2026.117204_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040810","article-title":"Inhibition of cochlear hmgb1 expression attenuates oxidative stress and inflammation in an experimental murine model of noise-induced hearing loss","volume":"10","author":"Shih","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.117204_bb0525","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/156720508785908937","article-title":"Evidence for altered LRP\/RAGE expression in Alzheimer lesion pathogenesis","volume":"5","author":"Jeynes","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0530","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jid.2019.03.1148","article-title":"Oxidative stress\u2013induced HMGB1 release from melanocytes: a paracrine mechanism underlying the cutaneous inflammation in vitiligo","volume":"139","author":"Cui","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2026.117204_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.113912","article-title":"Glycyrrhizin attenuates myocardial ischemia reperfusion injury by suppressing Inflammation, oxidative stress, and ferroptosis via the HMGB1-TLR4-GPX4 pathway","volume":"435","author":"Zhu","year":"2024","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0540","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","article-title":"Assessing mitochondrial dysfunction in cells","volume":"435","author":"Brand","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2026.117204_bb0545","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.intimp.2026.117204_bb0550","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/SHK.0000000000002006","article-title":"Cardiopulmonary bypass-derived plasma exosomal hmgb1 contributes to alveolar epithelial cell necroptosis via mtDNA\/CGAS\/Sting pathway","volume":"58","author":"Zhao","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2026.117204_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114902","article-title":"cGAS-STING and neurodegenerative diseases: A molecular crosstalk and therapeutic perspective","volume":"159","author":"Dhapola","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.117204_bb0560","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jnc.14450","article-title":"High-mobility group box 1 in Parkinson\u2019s disease: from pathogenesis to therapeutic approaches","volume":"146","author":"Angelopoulou","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.117204_bb0565","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020370","article-title":"Astrocytes control synapse formation, function, and elimination","volume":"7","author":"Chung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2026.117204_bb0570","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1152\/physrev.00027.2007","article-title":"Diffusion in brain extracellular space","volume":"88","author":"Sykov\u00e1","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2026.117204_bb0575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","article-title":"LTP and LTD: an embarrassment of riches","volume":"44","author":"Malenka","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.117204_bb0580","first-page":"1","article-title":"HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury","author":"Neuroinflammation","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117204_bb0585","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1016\/j.cell.2021.06.018","article-title":"GABA-receptive microglia selectively sculpt developing inhibitory circuits","volume":"184","author":"Favuzzi","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117204_bb0590","first-page":"985","article-title":"RAGE in inflammation: a new therapeutic target?","volume":"7","author":"Bierhaus","year":"2006","journal-title":"Curr. Opin. Investig. Drugs (London, Engl. 2000)"},{"key":"10.1016\/j.intimp.2026.117204_bb0595","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.117204_bb0600","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cei.12036","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis","volume":"172","author":"Uzawa","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2026.117204_bb0605","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12974-021-02274-0","article-title":"HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury","volume":"18","author":"Tan","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117204_bb0610","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.187.2.143","article-title":"Regulation of immune responses by NF-kappa B\/Rel transcription factor","volume":"187","author":"Sha","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0615","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.intimp.2026.117204_bb0620","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.117204_bb0625","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/jnc.14687","article-title":"Nuclear factor-kappa \u03b2 as a therapeutic target for Alzheimer\u2019s disease","volume":"150","author":"Jha","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.117204_bb0630","doi-asserted-by":"crossref","first-page":"25781","DOI":"10.1074\/jbc.M001235200","article-title":"The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-\u03b1 through nuclear factor-\u03baB, and by 17\u03b2-estradiol through Sp-1 in human vascular endothelial cells","volume":"275","author":"Tanaka","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117204_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer\u2019s Disease: Current Progress in Molecular Signaling and Therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2026.117204_bb0640","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1007\/s12035-016-9967-2","article-title":"Regulation of SET gene expression by NFkB","volume":"54","author":"Feng","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0645","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm0795-693","article-title":"Non-enzymatically glycated tau in Alzheimer\u2019s disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid \u03b2-peptide","volume":"1","author":"Du Yan","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0650","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","article-title":"Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective","volume":"10","author":"Gonz\u00e1lez-Reyes","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0655","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","article-title":"Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer\u2019s disease","author":"Kaur","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2026.117204_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00042","article-title":"Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer\u2019s Disease Brain: A Review","volume":"10","author":"Zhan","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0665","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145711000149","article-title":"Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease","volume":"15","author":"Chen","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.intimp.2026.117204_bb0670","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07331.x","article-title":"AMP-activated protein kinase: a potential player in Alzheimer\u2019s disease","volume":"118","author":"Salminen","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.117204_bb0675","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neurobiolaging.2011.09.039","article-title":"A\u03b2-induced formation of autophagosomes is mediated by RAGE-CaMKK\u03b2-AMPK signaling","volume":"33","author":"Son","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.intimp.2026.117204_bb0680","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1084\/jem.20070247","article-title":"HMGB1 release induced by liver ischemia involves Toll-like receptor 4\u2013dependent reactive oxygen species production and calcium-mediated signaling","volume":"204","author":"Tsung","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117211","article-title":"Calcium dysregulation in Alzheimer\u2019s disease: unraveling the molecular nexus of neuronal dysfunction and therapeutic opportunities","volume":"242","author":"Chaudhary","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117204_bb0690","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2004.02.022","article-title":"Secreted beta-amyloid precursor protein activates microglia via JNK and p38-MAPK","volume":"26","author":"Bodles","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.intimp.2026.117204_bb0695","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","article-title":"Toll-like receptors and innate immunity","volume":"388","author":"Kumar","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2026.117204_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2005.11.004","article-title":"Differential role of MAPK signaling in human dendritic cell maturation and Th1\/Th2 engagement","volume":"42","author":"Nakahara","year":"2006","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2026.117204_bb0705","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-5793(95)00357-F","article-title":"SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1","volume":"364","author":"Cuenda","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.intimp.2026.117204_bb0710","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/hmg\/ddu475","article-title":"Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer\u2019s disease brain","volume":"24","author":"Tagawa","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.intimp.2026.117204_bb0715","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/356618a0","article-title":"MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium\u2013calmodulin","volume":"356","author":"Hartwig","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117204_bb0720","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1471-4159.1999.0721179.x","article-title":"Amyloid \u03b2 Protein (25-35) Phosphorylates MARCKS Through Tyrosine Kinase-Activated Protein Kinase C Signaling Pathway in Microglia","volume":"72","author":"Nakai","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.117204_bb0725","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/382716a0","article-title":"Scavenger receptor-mediated adhesion of microglia to \u03b2-amyloid fibrils","volume":"382","author":"El Khoury","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117204_bb0730","first-page":"2467","article-title":"Molecular characterization and modular analysis of human MyD88","volume":"13","author":"Hardiman","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2026.117204_bb0735","doi-asserted-by":"crossref","DOI":"10.1097\/01.shk.0000225404.51320.82","article-title":"HMGB1 signals through toll-like receptor (TLR) 4 and TLR2","volume":"26","author":"Yu","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2026.117204_bb0740","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fncel.2018.00026","article-title":"The Consequences of Preterm Birth and Chorioamnionitis on Brainstem Respiratory Centers: Implications for Neurochemical Development and Altered Functions by Inflammation and Prostaglandins","volume":"12","author":"Stojanovska","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"14","key":"10.1016\/j.intimp.2026.117204_bb0745","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0757.1997.tb00194.x","article-title":"Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease","volume":"2000","author":"Gemmell","year":"1997","journal-title":"Periodontol"},{"key":"10.1016\/j.intimp.2026.117204_bb0750","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin","volume":"270","author":"Hori","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117204_bb0755","article-title":"High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117204_bb0760","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.intimp.2026.117204_bb0765","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer\u2019s disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0770","article-title":"NF-\u03baB in neurodegenerative diseases: Recent evidence from human genetics","volume":"15-2022","author":"Kaltschmidt","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0775","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11064-008-9770-1","article-title":"GSK-3\u03b2 gene expression in human postmortem brain: regional distribution, effects of age and suicide","volume":"34","author":"Pandey","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0780","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/joor.13289","article-title":"Curcumin plays a local anti-inflammatory and antioxidant role via the HMGB1\/TLR4\/NF-\u039aB pathway in rat masseter muscle under psychological stress","volume":"49","author":"Miao","year":"2022","journal-title":"J. Oral Rehabil."},{"key":"10.1016\/j.intimp.2026.117204_bb0785","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4927430","article-title":"Curcumin attenuates asthmatic airway inflammation and mucus hypersecretion involving a PPAR\u03b3-dependent NF-\u03baB signaling pathway in vivo and in vitro","volume":"2019","author":"Zhu","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2026.117204_bb0790","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-170188","article-title":"The mechanisms of action of curcumin in Alzheimer\u2019s disease","volume":"58","author":"Tang","year":"2017","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.intimp.2026.117204_bb0795","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt146","article-title":"Oral curcumin for Alzheimer\u2019s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","volume":"4","author":"Ringman","year":"2012","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.intimp.2026.117204_bb0800","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ACO.0b013e3282f63c2e","article-title":"Ethyl pyruvate","volume":"21","author":"Fink","year":"2008","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-018-0006-9","article-title":"Identification of ethyl pyruvate as a NLRP3 inflammasome inhibitor that preserves mitochondrial integrity","volume":"24","author":"Li","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0810","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s12031-020-01489-9","article-title":"Neuroprotective Effects of Ethyl Pyruvate against Aluminum Chloride-Induced Alzheimer\u2019s Disease in Rats via Inhibiting Toll-Like Receptor 4","volume":"70","author":"Chavali","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0815","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.jvca.2008.08.005","article-title":"A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass","volume":"23","author":"Bennett-Guerrero","year":"2009","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.intimp.2026.117204_bb0820","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12950-016-0144-1","article-title":"Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries","volume":"13","author":"Yang","year":"2016","journal-title":"J. Inflamm."},{"key":"10.1016\/j.intimp.2026.117204_bb0825","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.chembiol.2007.03.007","article-title":"Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities","volume":"14","author":"Mollica","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.intimp.2026.117204_bb0830","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10571-012-9839-x","article-title":"The blood\u2013brain barrier permeability of 18\u03b2-glycyrrhetinic acid, a major metabolite of glycyrrhizin in glycyrrhiza root, a constituent of the traditional japanese medicine yokukansan","volume":"32","author":"Tabuchi","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0835","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molimm.2012.10.037","article-title":"HMGB1 and leukocyte migration during trauma and sterile inflammation","volume":"55","author":"Venereau","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.117204_bb0840","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/acschemneuro.9b00640","article-title":"Potential neuroprotective effect of the HMGB1 inhibitor glycyrrhizin in neurological disorders","volume":"11","author":"Paudel","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0845","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/jps.2600811018","article-title":"Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method","volume":"81","author":"Yamamura","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2026.117204_bb0850","doi-asserted-by":"crossref","first-page":"20348","DOI":"10.1074\/jbc.M115.662114","article-title":"Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1\u03b2 (IL-1\u03b2) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages*","volume":"290","author":"Kelly","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117204_bb0855","doi-asserted-by":"crossref","first-page":"92","DOI":"10.15616\/BSL.2019.25.1.92","article-title":"Anti-inflammatory effects of metformin on neuro-inflammation and NLRP3 Inflammasome activation in BV-2 microglial cells","volume":"25","author":"Ha","year":"2019","journal-title":"Biomed. Sci. Lett."},{"key":"10.1016\/j.intimp.2026.117204_bb0860","series-title":"Evidence-based Synthesis Program Metformin Use in Patients with Contraindications or Precautions","author":"Diamantidis","year":"2016"},{"key":"10.1016\/j.intimp.2026.117204_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155223","article-title":"Metformin: Is it a drug for all reasons and diseases?","volume":"133","author":"Triggle","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2026.117204_bb0870","volume":"39","author":"Luchsinger","year":"2025"},{"key":"10.1016\/j.intimp.2026.117204_bb0875","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid \u03b2\u2013mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117204_bb0880","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jpi.12194","article-title":"Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE\/NF-KB\/JNK signaling pathway in aging mouse model","volume":"58","author":"Ali","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.intimp.2026.117204_bb0885","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.3892\/mmr.2016.5700","article-title":"Activation of mTOR signaling leads to orthopedic surgery-induced cognitive decline in mice through \u03b2-amyloid accumulation and tau phosphorylation","volume":"14","author":"Shen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2026.117204_bb0890","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/13543784.2015.1001490","article-title":"Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer\u2019s disease","volume":"24","author":"Walker","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.intimp.2026.117204_bb0895","article-title":"Progress of RAGE Molecular Imaging in Alzheimer\u2019s Disease","volume":"12-2020","author":"Kong","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0900","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.apsb.2020.11.012","article-title":"Targeting redox-altered plasticity to reactivate synaptic function: A novel therapeutic strategy for cognitive disorder","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2026.117204_bb0905","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41467-020-16080-4","article-title":"N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer\u2019s disease","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117204_bb0910","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41401-022-00888-5","article-title":"Trilobatin rescues cognitive impairment of Alzheimer\u2019s disease by targeting HMGB1 through mediating SIRT3\/SOD2 signaling pathway","volume":"43","author":"Gao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2026.117204_bb0915","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3298400","article-title":"Trilobatin alleviates cognitive deficits and pathologies in an Alzheimer\u2019s disease mouse model","volume":"2021","author":"Ding","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2026.117204_bb0920","doi-asserted-by":"crossref","first-page":"88","DOI":"10.21037\/atm.2019.12.147","article-title":"Protective effects of curcumin against neuroinflammation induced by A\u03b225-35 in primary rat microglia: modulation of high-mobility group box 1, toll-like receptor 4 and receptor for advanced glycation end products expression","volume":"8","author":"He","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117204_bb0925","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12031-017-0989-7","article-title":"The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer\u2019s-Related Pathology via HMGB1 Inhibition","volume":"63","author":"Kong","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.117204_bb0930","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.3390\/ijms26188782","article-title":"Inhibition of the HMGB1-RAGE Axis Attenuates Microglial Inflammation and Ameliorates Hypoxia-Induced Cognitive Impairment","volume":"26","author":"Liu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117204_bb0935","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10787-024-01598-6","article-title":"Shedding light on microglial dysregulation in Alzheimer\u2019s disease: exploring molecular mechanisms and therapeutic avenues","volume":"33","author":"Bhardwaj","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2026.117204_bb0945","doi-asserted-by":"crossref","DOI":"10.1002\/alz.046497","article-title":"Double-blind placebo-controlled trial of the safety and efficacy of GM-CSF\/sargramostim in subjects with mild-to-moderate Alzheimer\u2019s disease: Human\/Human trials: Cognitive enhancement","volume":"16","author":"Potter","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.intimp.2026.117204_bb0940","doi-asserted-by":"crossref","first-page":"149","DOI":"10.14283\/jpad.2018.18","article-title":"Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer\u2019s Disease","volume":"5","author":"Burstein","year":"2018","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.intimp.2026.117204_bb0950","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.intimp.2026.117204_bb0955","first-page":"273","article-title":"Neflamapimod: clinical phase 2b-ready oral small molecule inhibitor of p38\u03b1 to reverse synaptic dysfunction in early Alzheimer\u2019s disease","volume":"4","author":"Alam","year":"2017","journal-title":"J. Prev. Alzheimers Dis"},{"key":"10.1016\/j.intimp.2026.117204_bb0960","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1002\/jcp.30125","article-title":"HMGB1 as a therapeutic target in disease","volume":"236","author":"Xue","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2026.117204_bb0965","doi-asserted-by":"crossref","first-page":"21671","DOI":"10.1021\/acs.jmedchem.4c01912","article-title":"Targeting HMGB1 and its interaction with receptors: challenges and future directions","volume":"67","author":"Shen","year":"2024","journal-title":"J. Med. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:04:39Z","timestamp":1789142679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":192,"alternative-id":["S1567576926010507"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117204","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HMGB1 signalling in Alzheimer\u2019s disease: pathogenic roles and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117204"}}